Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Assessing outcome in head injury trials
Autore:
Wilson, JTL;
Indirizzi:
Univ Stirling, Dept Psychol, Stirling FK9 4LA, Scotland Univ Stirling Stirling Scotland FK9 4LA chol, Stirling FK9 4LA, Scotland
Titolo Testata:
CURRENT PHARMACEUTICAL DESIGN
fascicolo: 15, volume: 7, anno: 2001,
pagine: 1537 - 1552
SICI:
1381-6128(200110)7:15<1537:AOIHIT>2.0.ZU;2-J
Fonte:
ISI
Lingua:
ENG
Soggetto:
TRAUMATIC BRAIN INJURY; RANDOMIZED CONTROLLED TRIALS; MULTICENTER CLINICAL-TRIAL; DISABILITY RATING-SCALE; NEUROPROTECTIVE AGENTS; COGNITIVE SEQUELAE; STROKE TRIALS; CORTICOSTEROIDS; PREDICTION; HEMORRHAGE;
Tipo documento:
Review
Natura:
Periodico
Settore Disciplinare:
Life Sciences
Citazioni:
65
Recensione:
Indirizzi per estratti:
Indirizzo: Wilson, JTL Univ Stirling, Dept Psychol, Stirling FK9 4LA, Scotland Univ Stirling Stirling Scotland FK9 4LA ng FK9 4LA, Scotland
Citazione:
J.T.L. Wilson, "Assessing outcome in head injury trials", CUR PHARM D, 7(15), 2001, pp. 1537-1552

Abstract

It is often suggested that one reason that neuroprotection trials in head injury have not shown benefit is the insensitivity of the outcome measures employed. The review considers strengths and weaknesses of the main approaches to assessing outcome in head injury trials. Determination of a responseto neuroprotection. requires a measure that is both sensitive to differences in outcome and is also influenced by brain injury. Sets of tests have been proposed for use in clinical trials that include scales of disability and handicap and measures of neuropsychological impairment. The Glasgow Outcome Scale (GOS) covers the whole spectrum of outcome after head injury and is the most popular primary endpoint for head injury trials. Although the GOS is a simple scale, small changes in the distribution of outcome can be detected with appropriate sample sizes. Late outcome in survivors can be influenced by various personal and environmental factors in addition to initialbrain pathology. Other rating scales and questionnaires do not appear to offer significant advantages over the GOS, but can be used to supplement theinformation collected. Neuropsychological tests have properties that make them attractive as outcome measures, although there are practical difficulties with using tests. Neuropsychological assessment is potentially a powerful way of testing specific hypotheses concerning the effects of treatment. All current outcome measures have limitations; choice of the most appropriate endpoint will depend both on the properties of the measures available, and on the anticipated effects of treatment.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 03/04/20 alle ore 11:07:01